FLIXABI®, an Infliximab Biosimilar Candidate Referencing Remicade®, Receives Positive CHMP Biotech Investing
Vaxil Receives Canadian Notice of Patent Allowance for Its Lead Immunotherapy Platform, Including Its ImMucin(TM) Cancer Vaccine Biotech Investing
Cellceutix Successfully Completes In Vitro Study in Support of Planned Phase 2 Trial of Kevetrin for Ovarian Cancer Biotech Investing
Endonovo Therapeutics Receives USPTO Notice of Allowance for Patent Covering Production of Biomolecules From Adult Stem Cells Biotech Investing
Cellceutix Receives Preliminary Approval for Clinical Trial of Brilacidin for Ulcerative Proctitis Biotech Investing
Actinium Receives Orphan Drug Designation From FDA for Iomab-B in Treating Refractory and Relapsed Acute Myeloid Leukemia in Elderly Patients Biotech Investing
Critical Outcome Technologies Completes Private Placement With a Successful U.S. Life Science Investor Biotech Investing
Lattice Biologics and Sunnybrook Research Institute Commence Study to Develop New Cancer Screening Methods Biotech Investing
